Inovio Pharmaceuticals Inc (INO)

9.13
NASDAQ : Health Care
Prev Close 9.05
Day Low/High 9.00 / 9.25
52 Wk Low/High 4.50 / 11.69
Avg Volume 1.63M
Exchange NASDAQ
Shares Outstanding 73.10M
Market Cap 661.53M
EPS -0.40
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

'Mad Money' Lightning Round: Be Patient on Alcoa

'Mad Money' Lightning Round: Be Patient on Alcoa

Cramer loves Popeyes Louisiana Kitchen but he can't recommend Harman International right now.

Jim Cramer's 'Mad Money' Recap: 'Brexit' Means Nothing to U.S. Stocks

Jim Cramer's 'Mad Money' Recap: 'Brexit' Means Nothing to U.S. Stocks

There's been so much news coverage about whether the United Kingdom will leave the European Union that it's making us numb, Cramer says.

Inovio Pharmaceuticals (INO) Optimistic on Zika/Ebola Vaccine Progress

Inovio Pharmaceuticals (INO) Optimistic on Zika/Ebola Vaccine Progress

Rising Biotech Company Inovio believes that its simultaneous vaccine efforts are well on their way to approval from the FDA.

First Week of INO February 2017 Options Trading

First Week of INO February 2017 Options Trading

Investors in Inovio Pharmaceuticals Inc. saw new options become available this week, for the February 2017 expiration.

Inovio Pharmaceuticals (INO) Is Today's Strong On High Volume Stock

Inovio Pharmaceuticals (INO) Is Today's Strong On High Volume Stock

Trade-Ideas LLC identified Inovio Pharmaceuticals (INO) as a strong on high relative volume candidate

Strong On High Volume: Inovio Pharmaceuticals (INO)

Strong On High Volume: Inovio Pharmaceuticals (INO)

Trade-Ideas LLC identified Inovio Pharmaceuticals (INO) as a strong on high relative volume candidate

Inovio Pharmaceuticals Zika Vaccine Produces Robust Immune Responses In Non-Human Primates

Inovio Pharmaceuticals Zika Vaccine Produces Robust Immune Responses In Non-Human Primates

Inovio will conduct human studies later this year

Trade-Ideas: Inovio Pharmaceuticals (INO) Is Today's

Trade-Ideas: Inovio Pharmaceuticals (INO) Is Today's "Perilous Reversal" Stock

Trade-Ideas LLC identified Inovio Pharmaceuticals (INO) as a "perilous reversal" (up big yesterday but down big today) candidate

Strong On High Relative Volume: Inovio Pharmaceuticals (INO)

Strong On High Relative Volume: Inovio Pharmaceuticals (INO)

Trade-Ideas LLC identified Inovio Pharmaceuticals (INO) as a strong on high relative volume candidate

Inovio Pharmaceuticals (INO) Highlighted As Weak On High Volume

Inovio Pharmaceuticals (INO) Highlighted As Weak On High Volume

Trade-Ideas LLC identified Inovio Pharmaceuticals (INO) as a weak on high relative volume candidate

'Mad Money' Lightning Round: Buy, Buy, Buy Bojangles

'Mad Money' Lightning Round: Buy, Buy, Buy Bojangles

Cramer is not recommending Baidu and is staying away from Ruckus Wireless.

Jim Cramer's 'Mad Money' Recap: Don't Freak Out

Jim Cramer's 'Mad Money' Recap: Don't Freak Out

Selloffs create opportunities, Cramer says.

Inovio Pharmaceuticals Showcases Its Broad Pipeline of DNA-based Immunotherapies, Vaccines And DMAbs at The American Society Of Gene & Cell Therapy

Inovio Pharmaceuticals Showcases Its Broad Pipeline of DNA-based Immunotherapies, Vaccines And DMAbs at The American Society Of Gene & Cell Therapy

Worldwide Scientific Forum Selects Inovio's Ebola Vaccine Challenge Results for its Presidential Symposium

Inovio Pharmaceuticals (INO) Is Today's Dead Cat Bounce Stock

Inovio Pharmaceuticals (INO) Is Today's Dead Cat Bounce Stock

Trade-Ideas LLC identified Inovio Pharmaceuticals (INO) as a "dead cat bounce" (down big yesterday but up big today) candidate

Inovio Pharmaceuticals Completes Acquisition Of Needle-Free Injection Technology

Inovio Pharmaceuticals Completes Acquisition Of Needle-Free Injection Technology

Inovio will integrate needle-free injection with needle-free electroporation delivery in next-generation device for large-population vaccine administration

2 Small-Cap Biotechs With Big Ambitions

Inovio Pharmaceuticals and Eagle Pharmaceuticals both boast solid pipelines and sound balance sheets.

Inovio Partners With National Cancer Institute And Mayo Clinic To Initiate Hepatitis C Immunotherapy Clinical Trial

Inovio Partners With National Cancer Institute And Mayo Clinic To Initiate Hepatitis C Immunotherapy Clinical Trial

DNA-based immunotherapy will be tested for safety and immune responses in quest to eliminate HCV infection

4 Biotech Stocks You Should Be Watching Right Now

4 Biotech Stocks You Should Be Watching Right Now

Biotech stocks are dominating the strong stock charts on our radar.

Trader's Notebook: Searching for Bullish Excess in the Banks

Looking for a breakout on banks and bonds. 

5 Stocks Insiders Love Right Now

5 Stocks Insiders Love Right Now

Insiders at these companies are scooping up shares of their own stock lately.

Trader's Notebook: Handling the After-Hours Selling

Here's what to make of the selling in IBM and Netflix that came after earnings and after the bell. 

Trader's Notebook: Handling the After-Hours Selling

Here's what to make of the selling in IBM and Netflix that came after earnings and after the bell. 

Interesting INO Put And Call Options For June 17th

Interesting INO Put And Call Options For June 17th

Investors in Inovio Pharmaceuticals Inc. saw new options become available today, for the June 17th expiration.

Trader's Notebook: Don't Read too Much Into Twitter's High

Also a stock to combat the Zika virus, and another that fights off viruses of the cyber kind.